Japan's PMDA warns of serious AEs with pivoxil use in kids

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2012年 / 1407卷 / 1期

关键词：

Public Health; Adverse Event; Otitis Medium; Carnitine; Medical Device;

D O I：

10.2165/00128415-201214070-00003

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：2 / 2

相关论文

共 50 条

[21] Japan's PMDA releases updated risk report for telaprevir
Reactions Weekly, 2012, 1408 (1) : 2 - 2
[22] Japan's PMDA releases investigation results for 4 products
Reactions Weekly, 2015, 1541 (1) : 5 - 5
[23] Japan PMDA's recommends revised precautions for various products
Reactions Weekly, 2020, 1806 (1) : 5 - 5
[24] Japan's PMDA releases investigation results for 4 products
Reactions Weekly, 2016, 1590 (1) : 3 - 3
[25] Package insert revisions required: Japan's PMDA findings
Reactions Weekly, 2016, 1615 (1) : 4 - 4
[26] Japan's PMDA revises package inserts for memantine, bevacizumab
Reactions Weekly, 2020, 1810 (1) : 2 - 2
[27] Japan's PMDA releases investigation results for 8 products
Reactions Weekly, 2016, 1595 (1) : 5 - 5
[28] Japan's MHLW/PMDA recommends package insert revisions
Reactions Weekly, 2018, 1732 (1) : 1 - 1
[29] Japan's PMDA issues precautions update for aminolevulinic acid hydrochloride
Reactions Weekly, 2022, 1891 (1) : 1 - 1
[30] Use of opioids with naltrexone/bupropion may cause serious AEs
Reactions Weekly, 2024, 2020 (1) : 6 - 6

← 1 2 3 4 5 →